Quality of life related with health in adults with hemophilia from a health program in Medellín, Colombia
DOI:
https://doi.org/10.17533/udea.iatreia.82Keywords:
adult, Latin America, quality of life, hemophilia A, hemophilia BAbstract
Objective: To determine the quality of life related to health in adults with hemophilia affiliated with a coagulopathic disorders program and to explore its association with clinical and demographic factors.
Design: A cross sectional and descriptive study was performed. The hemophilia-specific quality of life questionnaire in Latin America (Hemolatin-QoL) was applied to all hemophilia patients at a specialized clinic in Medellín (Colombia). Descriptive statistical measures were used, and the factors associated with the different dimensions of quality of life were evaluated using the Kruskall-Wallis test and the Spearman correlation coefficient.
Results: Forty-eight adults were included, with a median age of 32 years old (RI: 23.2-40.7). The population
varied in the severity of hemophilia (16.7% mild, 12.5% moderate, and 70.8% severe) and in treatment
(75% prophylaxis, 22.9% demand and 2.1% immunotolerance.), 37.5% had reduced mobility, while 16.7% suffered from comorbidity. The total Hemolatin-Qol score was 81.5. The factors associated with lower quality
of life were: older age, number of comorbidities, low socioeconomic level, presence of arthropathy and reduced mobility.
Conclusions: The quality of life scores obtained by the study were close to the maximum possible score of the questionnaire. The factors associated with quality of life are similar to those found in other populations and are related to economic difficulties, other diseases and disability. Further longitudinal studies with a larger sample are necessary to establish causal associations.
Downloads
References
(1) Mahlangu J, Oldenburg J, Callaghan MU, Shima M, Mancuso ME, Trask P, et al. Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS). Haemophilia. 2019;25(3):382-391. DOI 10.1111/hae.13731.
(2) Srivastava A, Santagostino A, Dougall A, Kitchen S, Sutherland M, Steven W, et al. WFH Guidelines for the Management of Hemophilia. 3rd. Montreal: WFH Haemophilia; 2020.
(3) Federación mundial de la hemofilia (FMH). La hemofilia en imágenes. Guía del educador [internet]. [Consultado 2020 abr 2]. Disponible en: https://n9.cl/5vqt
(4) Federación mundial de la hemofilia (FMH). Cuidados generales y tratamiento de la hemofilia [internet].[Consultado 2020 feb 18]. Disponible en: https://n9.cl/hqoe
(5) O´Mahony B. Sociedades de hemofilia: desafíos y desarrollo [internet]. Québec: FMH. 2011. [Consultado 2020 ago 30]. Disponible en: https://n9.cl/h841b
(6) Colombia. Ministerio de protección social y salud. Protocolo clínico para tratamiento con profilaxis de personas con hemofilia A sin inhibidores. 2015 [internet]. [Consultado 2015 jun 04]. Disponible en: https://n9.cl/smzk
(7) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403-1409. DOI 10.1016/0277-9536(95)00112-k.
(8) Naughton MJ, Shumaker SA, Anderson RT, Czajkowski SM. Psychological Aspects of Health-Related Quality of Life Measurement: Tests and Scales. In: Quality of Life and Pharmaco economics in Clinical Trials 1996;15:117-31.
(9) Bullinger M, Globe D, Wasserman J, Young NL, von Mackensen S. Challenges of patient-reported outcome assessment in hemophilia care—a state of the art review. Value Health. 2009;12(5):808-820. DOI 10.1111/j.1524-4733.2009.00523.x.
(10) Gringeri A, Von Mackensen S. Quality of life in haemophilia. Haemophilia. 2008;14(SUPPL. 3):19–25.
(11) Boehien F, Graf L, Berntorp E. Outcome measures in haemophilia: a Systematic Review. Eur J Haemotol. 2014;93:2-15.
(12) Limperg PF, Terwee CB, Young NL, Price VE, Gouw SC, Peters M, et al. Health-related quality of life questionnaires in individuals with haemophilia: a systematic review of their measurement properties. Haemophilia. 2017;23(4):497-510. DOI 10.1111/hae.13197.
(13) Remor E. Desarrollo de una Medida Específica para la Evaluación de la Calidad de Vida en Pacientes Adultos Viviendo con Hemofilia en América-Latina: el Hemolatin-QoL. R. interam. Psicol. 2005;39(2):211-20.
(14) Remor E. Psychometric field testing of the HemoLatin-QoL questionnaire. Haemophilia. 2016;22(5):e390-e400. DOI 10.1111/hae.13055.
(15) Cuenta de alto costo. Situación de la hemofilia en Colombia (2015) [internet]. [Consultado 2016 mar 07]. Disponible en: https://n9.cl/d4pr
(16) World Federation of Hemophilia (WFH). Report on the Annual Global Survey 2016 [internet]. [Consultado 2017 oct 11]. Disponible en: https://n9.cl/r9nc5
(17) Cuenta de alto costo. Situación de la hemofilia en Colombia (2018) [internet]. [Consultado 2019 feb 03]. Disponible en: https://n9.cl/nfbj
(18) Cuenta de alto costo. Situación de la hemofilia en Colombia (2016) [internet]. [Consultado 2017 sep 20]. Disponible en: https://n9.cl/fxt2
(19) Fuenmayor A, Jaramillo M, Salinas F. Calidad de vida en una población con hemofilia: estudio de corte transversal en un centro de tratamiento de hemofilia. Rev Colomb Reumatol. 2017;24(1):18-24.
(20) Duncan N, Shapiro A, Ye X, Epstein J, Luo MP. Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Haemophilia. 2012;18(5):760-5. DOI 10.1111/j.1365-2516.2012.02813.x.
(21) Franchini M, Mannucci PM. Co-morbidities and quality of life in elderly persons with haemophilia. Br J Haematol. 2010;148(4):522-533. DOI 10.1111/j.1365-2141.2009.08005.x.
(22) Poon JL, Zhou ZY, Doctor JN, Wu J, Ullman MM, Ross C, et al. Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va). Haemophilia. 2012;18(5):699-707. DOI 10.1111/j.1365-2516.2012.02791.x.
(23) Von Mackensen S, Gringeri A, Siboni SM, Mannucci PM; Italian Association Of Haemophilia Centres (AICE). Health-related quality of life and psychological well-being in elderly patients with haemophilia. Haemophilia. 2012;18(3):345-352. DOI 10.1111/j.1365-2516.2011.02643.x.
(24) American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed [internet]. Washington, DC: The Association; 2013. [Consultado 2016 jul 20]. Disponible en: https://n9.cl/4uspk
(25) Colombia. Ministerio de protección social y salud. Contenidos mínimos para la conformación de programas para la atención integral de pacientes con diagnóstico de hemofilia y otras coagulopatías; 2017 [internet]. [Consultado 2018 oct 04]. Disponible en: https://n9.cl/tugie
(26) Oladapo AO, Epstein JD, Williams E, Ito D, Gringeri A, Valentino LA. Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials. Haemophilia. 2015;21(5):e344-e358. DOI 10.1111/hae.12759.
(27) Santagostino E, Lentz SR, Busk AK, Regnault A, Iorio A. Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa. Haemophilia. 2014;20(4):527-54. DOI 10.1111/hae.12371.
(28) Brown TM, Lee WC, Joshi AV, Pashos CL. Health-related quality of life and productivity impact in haemophilia patients with inhibitors. Haemophilia. 2009;15(4):911-7. DOI 10.1111/j.1365-2516.2009.02032.x.
(29) Klamroth R, Pollmann H, Hermans C, Faradji A, Yarlas AS, Epstein JD, et al. The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study. Haemophilia. 2011;17(3):412-421. DOI 10.1111/j.1365-2516.2010.02435.x.
(30) Khawaji M, Astermark J, Berntorp E. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life. Eur J Haematol. 2012;88(4):329-35. DOI 10.1111/j.1600-0609.2012.01750.x.
(31) Ferreira AA, Leite IC, Bustamante-Teixeira MT, Lima Corrêa CS, da Cruz DT, Werneck Rodrigues DO, et al. Health-related quality of life in hemophilia: results of the Hemophilia-Specific Quality of Life Index (Haem-a-Qol) at a Brazilian blood center. Rev Bras Hematol Hemoter. 2013;35(5):314-8. DOI 10.5581/1516-8484.20130108.
(32) Varaklioti A, Kontodimopoulos N, Katsarou O, Niakas D. Psychometric properties of the Greek Haem-AQoL for measuring quality of life in Greek haemophilia patients. Biomed Res Int. 2014;2014:968081. DOI 10.1155/2014/968081.
(33) Iannone M, Pennick L, Tom A, et al. Prevalence of depression in adults with haemophilia. Haemophilia. 2012;18(6):868-874. DOI 10.1111/j.1365-2516.2012.02863.x.
(34) Pinto PR, Paredes AC, Moreira P, et al. Emotional distress in haemophilia: Factors associated with the presence of anxiety and depression symptoms among adults. Haemophilia. 2018;24(5):e344-e353. DOI 10.1111/hae.13548.
(35) Cassis F. Atención psicosocial para personas con hemofilia. Tratamiento de la hemofilia. Federación mundial de la hemofilia [internet]. [Consultado 2014 sep 18]. Disponible en: https://n9.cl/i6ql
(36) Muñoz LF, Palacios X. Calidad de vida y hemofilia: Una revisión de la literatura. Revista CES Psicología. 2015;8(1):169-91.
(37) Olsson A, Hellgren M, Berntorp E, Baghaei F. Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophilia. Haemophilia. 2015;21(6):742-6. DOI 10.1111/hae.12796.
(38) Ratajová K, Blatný J, Poláčková Šolcová I, Meier Z, Horňáková T, Brnka R, et al. Social support and resilience in persons with severe haemophilia: An interpretative phenomenological analysis. Haemophilia. 2020;26(3):e74-e80. DOI 10.1111/hae.13999.
(39) Cassis FR, Querol F, Forsyth A, Iorio A; HERO International Advisory Board. Psychosocial aspects of haemophilia: a systematic review of methodologies and findings. Haemophilia. 2012;18(3):e101-e114. DOI 10.1111/j.1365-2516.2011.02683.x.
(40) Dolatkhah R, Fakhari A, Pezeshki MZ, Shabanlouei R, Tavassoli N, Gholchin M. Social determinants and health-related dimensions of quality of life in adult patients with haemophilia. Haemophilia. 2014;20(3):376-381. DOI 10.1111/hae.12321.
(41) Carvalhosa AM, Henrard S, Lambert C, Hermans C. Physical and mental quality of life in adult patients with haemophilia in Belgium: the impact of financial issues. Haemophilia. 2014;20(4):479-485. DOI 10.1111/hae.12341.
(42) Salomon T, Chaves DG, Brener S, Martins PRJ, Mambrini JVM, Peixoto SV. Determining the health-related quality of life in individuals with haemophilia in developing economies: results from the Brazilian population. Haemophilia. 2017;23(1):42-9. DOI 10.1111/hae.13130.
(43) Solovieva S, Santavirta N, Santavirta S, Konttinen YT. Assessing quality of life in individuals with hereditary blood coagulation disorders. Qual Life Res. 2004;13(5):987-1000. DOI 10.1023/B:QURE.0000025587.97216.8a.
(44) Chen CM, Huang KC, Chen CC, et al. The impact of joint range of motion limitations on health-related quality of life in patients with haemophilia A: a prospective study. Haemophilia. 2015;21(3):e176-e184. DOI 10.1111/hae.12644.
(45) Kempton CL, Recht M, Neff A, Wang M, Buckner TW, Soni A, et al. Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study. Haemophilia. 2018;24(2):261-70. DOI 10.1111/hae.13377.
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
